BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6165734)

  • 1. The growth hormone dependence of a somatomedin-binding protein in human serum.
    White RM; Nissley SP; Moses AC; Rechler MM; Johnsonbaugh RE
    J Clin Endocrinol Metab; 1981 Jul; 53(1):49-57. PubMed ID: 6165734
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.
    Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins.
    Ranke MB; Blum WF; Bierich JR
    Acta Paediatr Scand Suppl; 1988; 347():114-26. PubMed ID: 2473597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture.
    Moses AC; Nissley SP; Passamani J; White RM
    Endocrinology; 1979 Feb; 104(2):536-46. PubMed ID: 446374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth hormone for therapy of development disorders in pediatric patients with hemodialysis for chronic kidney failure].
    Shizume K; Kawaguchi H; Ito K
    Nihon Rinsho; 1991 Dec; 49 Suppl():787-92. PubMed ID: 1725533
    [No Abstract]   [Full Text] [Related]  

  • 6. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
    Binoux M; Seurin D; Lassarre C; Gourmelen M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
    Cohen DA; Blethen SL
    J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
    Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
    Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited.
    Rosenfeld RG; Albertsson-Wikland K; Cassorla F; Frasier SD; Hasegawa Y; Hintz RL; Lafranchi S; Lippe B; Loriaux L; Melmed S
    J Clin Endocrinol Metab; 1995 May; 80(5):1532-40. PubMed ID: 7538145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.
    Hintz RL; Liu F; Rosenfeld RG; Kemp SF
    J Clin Endocrinol Metab; 1981 Jul; 53(1):100-4. PubMed ID: 6165729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.
    Blum WF; Ranke MB; Kietzmann K; Gauggel E; Zeisel HJ; Bierich JR
    J Clin Endocrinol Metab; 1990 May; 70(5):1292-8. PubMed ID: 1692331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenic changes in multiplication-stimulating activity binding to tissues and serum somatomedin-like receptor activity in the ovine fetus.
    Owens PC; Brinsmead MW; Waters MJ; Thorburn GD
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1812-20. PubMed ID: 6160856
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiplication-stimulating activity (MSA): a somatomedin-like polypeptide from cultured rat liver cells.
    Nissley SP; Rechler MM
    Natl Cancer Inst Monogr; 1978 May; (48):167-77. PubMed ID: 748750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay.
    Daughaday WH; Kapadia M; Mariz I
    J Lab Clin Med; 1987 Mar; 109(3):355-63. PubMed ID: 2434590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
    Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay.
    Drop SL; Kortleve DJ; Guyda HJ
    J Clin Endocrinol Metab; 1984 Nov; 59(5):899-907. PubMed ID: 6207199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk.
    Baxter RC; Zaltsman Z; Turtle JR
    J Clin Endocrinol Metab; 1984 Jun; 58(6):955-9. PubMed ID: 6202711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone.
    Lee PD; Durham SK; Martinez V; Vasconez O; Powell DR; Guevara-Aguirre J
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2266-74. PubMed ID: 9215305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.